Biocept (BIOC) Secures Patent on Target Selector Oncogene Mutation Enrichment & Detection Liquid Biopsy ctDNA Platform
Tweet Send to a Friend
Biocept, Inc. (NASDAQ: BIOC) announces the issuance of U.S. Patent No. 9,834,817, entitled METHODS FOR DETECTING NUCLEIC ACID SEQUENCE VARIANTS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
